Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Sezary Syndrome 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Cancer Prevention 1

Interventions

Peripheral Blood Stem Cell Transplantation 36fludarabine phosphate 32Cyclophosphamide 30Mycophenolic Acid 26Whole-Body Irradiation 23Tacrolimus 22Cyclosporine 20Busulfan 16Antilymphocyte Serum 16Methotrexate 14Radiotherapy 13Filgrastim 12Flow Cytometry 11Etoposide 11Methylprednisolone 8Melphalan 8Therapeutics 7Rituximab 7Lenalidomide 7Psychiatric Rehabilitation 6Cord Blood Stem Cell Transplantation 6Bortezomib 6Transplantation 5Sirolimus 5Polymerase Chain Reaction 5Gemcitabine 5Everolimus 5Brentuximab Vedotin 5Alemtuzumab 5pembrolizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Sezary Syndrome × Motion Pictures × Clear all
NCT00969085 2012-09-07

Trial of Curcumin in Cutaneous T-cell Lymphoma Patients

M.D. Anderson Cancer Center

Phase 2 Withdrawn
DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡